Latest News and Press Releases

AVITA Medical to host Acute Wound Care Showcase 2025 via webcast on May 13, with leadership insights, product highlights, and clinical outcomes.

AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on February 18, 2025 at 2:00PM PT.

VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care...

AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.

AVITA Medical announces industry leader, Robin VanDenburgh, has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024.

AVITA Medical expands portfolio with unique collagen dermal matrix through an exclusive development and distribution agreement with Regenity Biosciences.

Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.

AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.

AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.